At € 960.0 million, sales of the PCC Group in fiscal 2024 were just
below the billion euro mark, falling € 33.6 million or 3.4 % short of
the previous year’s figure of € 993.6 million. Our sales expectations
for the 2024 fiscal year were therefore not achieved. Average selling prices continued to fall in some segments. This was offset in some
cases by volume growth despite continued weak demand due to
the economic situation.
The performance of the six operating segments of the PCC Group varied. While the Chlorine & Derivatives segment recorded the largest nominal year-on-year decline in revenues, the Surfactants & Derivatives, Silicon & Derivatives and Logistics segments were each able to increase their sales. The Logistics segment recorded the largest increase in revenues. The Surfactants & Derivatives segment was the main sales driver in the Group. Volume growth and market share gains in some applications supported this development. The Chlorine & Derivatives segment again made the largest contribution to earnings before interest, taxes, depreciation and amortization (EBITDA) in fiscal 2024, followed by the Logistics, Surfactants & Derivatives and Polyols & Derivatives segments. The only segment with a negative contribution was Silicon & Derivatives, although it should be emphasized that this segment’s EBITDA improved by around 23 % compared to the previous year. Nevertheless, this negative contribution pushed the consolidated net result into the red in the mid-double-digit million euro range. Details of the different business developments in the individual segments and the Group as a whole can be found in the following detailed analysis.
The performance of the six operating segments of the PCC Group varied. While the Chlorine & Derivatives segment recorded the largest nominal year-on-year decline in revenues, the Surfactants & Derivatives, Silicon & Derivatives and Logistics segments were each able to increase their sales. The Logistics segment recorded the largest increase in revenues. The Surfactants & Derivatives segment was the main sales driver in the Group. Volume growth and market share gains in some applications supported this development. The Chlorine & Derivatives segment again made the largest contribution to earnings before interest, taxes, depreciation and amortization (EBITDA) in fiscal 2024, followed by the Logistics, Surfactants & Derivatives and Polyols & Derivatives segments. The only segment with a negative contribution was Silicon & Derivatives, although it should be emphasized that this segment’s EBITDA improved by around 23 % compared to the previous year. Nevertheless, this negative contribution pushed the consolidated net result into the red in the mid-double-digit million euro range. Details of the different business developments in the individual segments and the Group as a whole can be found in the following detailed analysis.
Sales by segment
G_L_03
